rinri-therapeutics2025-10-10T15:46:11+00:00Rinri Therapeutics awarded $1m Grand Prize at Life Sciences Innovation Summit in Riyadh, Saudi ArabiaPress Release October 2nd, 2025
rinri-therapeutics2025-09-05T05:38:56+00:00Mytos Announces Strategic Partnerships with StemSight, Rinri Therapeutics, and Novadip to Power Next-Generation Cell Therapy TrialsPress Release September 3rd, 2025
rinri-therapeutics2025-07-01T06:55:12+00:00UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing LossPress Release July 1st, 2025
rinri-therapeutics2025-01-14T17:43:47+00:00Rinri Therapeutics starts transformational year at JP Morgan conference, discussing upcoming first-in-human trial in neural hearing lossPress Release January 14th, 2025
rinri-therapeutics2025-01-14T17:44:52+00:00Novel procedure for cell delivery in Rinri Therapeutics’ first clinical trial described in peer-reviewed publicationPress Release November 11th, 2024
rinri-therapeutics2024-11-11T06:54:42+00:00Rinri Therapeutics latest article has been published by Otology and Neurotology.Press Release July 2nd, 2024
rinri-therapeutics2024-04-29T06:48:21+00:00Rinri Therapeutics Announces New Chair as It Approaches First Clinical TrialPress Release April 29th, 2024
rinri-therapeutics2024-03-05T10:01:16+00:00World’s first self-monitored cochlear implant trial opens the door to future hearing loss therapiesPress Release December 13th, 2022
rinri-therapeutics2024-03-05T12:52:54+00:00International research coalition verifies safe surgical access to the central core of the human cochlea for the very first timePress Release November 9th, 2022
